Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Di Rocco A, Lodi Rizzini E, Cindolo L, Licari M, Lavelli V, Nuvoli S, De Angelis C, Dionisi V, Ferrari C, De Vincentis G. Frantellizzi V, et al. Among authors: mascia m. Ann Nucl Med. 2020 Oct;34(10):772-780. doi: 10.1007/s12149-020-01501-7. Epub 2020 Jul 11. Ann Nucl Med. 2020. PMID: 32654030 Free PMC article.
Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.
Frantellizzi V, Costa R, Mascia M, Spanu A, Farcomeni A, Licari M, Cindolo L, Nuvoli S, Pontico M, De Vincentis G. Frantellizzi V, et al. Among authors: mascia m. Clin Genitourin Cancer. 2020 Jun;18(3):185-191. doi: 10.1016/j.clgc.2019.10.009. Epub 2019 Oct 16. Clin Genitourin Cancer. 2020. PMID: 32173355
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Murabito A, Lavelli V, Nuvoli S, Cosma L, Dionisi V, Nappi AG, Andreola M, De Vincentis G. Frantellizzi V, et al. Among authors: mascia m. Aging Clin Exp Res. 2021 Mar;33(3):651-658. doi: 10.1007/s40520-020-01573-5. Epub 2020 May 1. Aging Clin Exp Res. 2021. PMID: 32358729
Radium-223 in mCPRC patients: a large real-life Italian multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa RP, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Tripoli V, Lavelli V, Nuvoli S, Pontico M, Dionisi V, Ferrari C, DE Vincentis G. Frantellizzi V, et al. Among authors: mascia m. Minerva Urol Nephrol. 2022 Feb;74(1):21-28. doi: 10.23736/S2724-6051.20.03808-4. Epub 2020 Aug 4. Minerva Urol Nephrol. 2022. PMID: 32748619 Free article.
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Licari M, Lavelli V, Nuvoli S, Ricci M, Dionisi V, Nappi AG, De Vincentis G. Frantellizzi V, et al. Among authors: mascia m. Int J Radiat Biol. 2020 Dec;96(12):1608-1613. doi: 10.1080/09553002.2020.1838655. Epub 2020 Nov 3. Int J Radiat Biol. 2020. PMID: 33074066 Clinical Trial.
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Bauckneht M, Rebuzzi SE, Signori A, Frantellizzi V, Murianni V, Lodi Rizzini E, Mascia M, Lavelli V, Donegani MI, Ponzano M, Gaudiano A, Stazza ML, Licari M, Cavallini L, Laghi V, Cindolo L, Maggi M, Sciarra A, Mammucci P, Sambuceti G, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: mascia m. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1063-1074. doi: 10.1007/s00259-021-05550-6. Epub 2021 Sep 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 34486070 Free PMC article.
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Bauckneht M, Rebuzzi SE, Ponzano M, Borea R, Signori A, Frantellizzi V, Lodi Rizzini E, Mascia M, Lavelli V, Miceli A, De Feo MS, Pisani AR, Nuvoli S, Tripoli V, Morganti AG, Mammucci P, Caponnetto S, Mantica G, Di Nicola AD, Villano C, Cindolo L, Morbelli S, Sambuceti G, Fanti S, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: mascia m. Cancers (Basel). 2022 Mar 29;14(7):1744. doi: 10.3390/cancers14071744. Cancers (Basel). 2022. PMID: 35406515 Free PMC article.
Oromandibular dystonia: from onset to spread a multicenter italian study.
Trinchillo A, Esposito M, Terranova C, Rizzo V, Fabbrini G, Ferrazzano G, Belvisi D, Erro R, Barone P, Bono F, Di Biasio F, Bentivoglio AR, Lettieri C, Altavista MC, Scaglione CLM, Albanese A, Mascia MM, Muroni A, Pisani A, Berardelli A, Defazio G. Trinchillo A, et al. Among authors: mascia mm. Neurol Sci. 2024 Mar 27. doi: 10.1007/s10072-024-07488-7. Online ahead of print. Neurol Sci. 2024. PMID: 38536550
289 results